You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 44 No. 12, December 1987 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Neuroendocrine Response to 5-Hydroxytryptophan in Seasonal Affective Disorder

Frederick M. Jacobsen, MD, MPH; David A. Sack, MD; Thomas A. Wehr, MD; Susan Rogers, RN; Norman E. Rosenthal, MD

Arch Gen Psychiatry. 1987;44(12):1086-1091.


Abstract

• A double-blind random-ordered comparison of the effects of placebo and 5-hydroxytryptophan (200 mg, orally) in ten depressed patients with seasonal affective disorder (SAD) and ten controls disclosed slightly but significantly higher basal levels of serum prolactin and a trend toward higher basal levels of serum cortisol in the patients with SAD compared with controls. After administration of 5-HTP, the cortisol level significantly increased and the prolactin level significantly decreased in both patients and controls. No differences in the melatonin level, growth hormone level, blood pressure, or pulse rate and no side effects were noted between patients and controls in the two study conditions; the timing of basal and 5-hydroxytryptophan-stimulated hormonal secretions was similar for both groups. These results are discussed with reference to current hypotheses of the cause of SAD.



Author Affiliations

From the Clinical Psychobiology Branch, National Institute of Mental Health, Bethesda, Md.


Footnotes

Accepted for publication July 22, 1987.

Reprint requests to Clinical Psychobiology Branch, National Institute of Mental Health, Bldg 10, Room 4-South 239, 9000 Rockville Pike, Bethesda, MD 20892 (Dr Jacobsen).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Morning vs Evening Light Treatment of Patients With Winter Depression
Lewy et al.
Arch Gen Psychiatry 1998;55:890-896.
ABSTRACT | FULL TEXT  

Effects of Tryptophan Depletion vs Catecholamine Depletion in Patients With Seasonal Affective Disorder in Remission With Light Therapy
Neumeister et al.
Arch Gen Psychiatry 1998;55:524-530.
ABSTRACT | FULL TEXT  

Hormonal and Subjective Responses to Intravenous m-Chlorophenylpiperazine in Women With Seasonal Affective Disorder
Levitan et al.
Arch Gen Psychiatry 1998;55:244-249.
ABSTRACT | FULL TEXT  

Effects of Meta-chlorophenylpiperazine Infusions in Patients With Seasonal Affective Disorder and Healthy Control Subjects: Diurnal Responses and Nocturnal Regulatory Mechanisms
Schwartz et al.
Arch Gen Psychiatry 1997;54:375-385.
ABSTRACT  

Seasonal Independence of Low Prolactin Concentration and High Spontaneous Eye Blink Rates in Unipolar and Bipolar II Seasonal Affective Disorder
Depue et al.
Arch Gen Psychiatry 1990;47:356-364.
ABSTRACT  

Neurobiology of Seasonal Affective Disorder and Phototherapy
Skwerer et al.
J Biol Rhythms 1988;3:135-154.
 





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1987 American Medical Association. All Rights Reserved.